SWOT Analysis for NeuroPace Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Increasing Revenue every Quarter for the past 4 Quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Increasing profits every quarter for the past 3 quarters
Top Gainers
Stock with Low PE (PE < = 10)
Biggest Price Gainers from Open
Highest Recovery from 52 Week Low

Companies with growing costs YoY for long term projects
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
RSI indicating price weakness